FOREZBI

By: Glaxo Group Limited

Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; ...


Logo Design and Free Alerts provided by Trademarks On Call, Inc.

Status Alert: On Tuesday, May 19, 2026, the status for the FOREZBI mark changed to NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER .

On Tuesday, May 19, 2026, a U.S federal trademark application was filed for FOREZBI by Glaxo Group Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage.

The USPTO has assigned the FOREZBI mark the serial number 99831777. The FOREZBI mark has been filed in the category Pharmaceutical Products.

The owner of the FOREZBI mark is listed as Glaxo Group Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage. The correspondent for the FOREZBI mark is Christopher M. Hanes GSK of 410 Blackwell Street, Durham, NC 27701, United States. If you have licensing, usage or other questions concerning the FOREZBI mark, please contact the owner through the listed correspondent.

The description provided for the FOREZBI mark is Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; ...
Word Mark: FOREZBI
Status: NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status Date: 05/19/2026
Serial Number: 99831777
Filing Date: 05/19/2026
Registration Number: Not Available
Registration Date: Not Available
Goods and Services: Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives
Type Of Mark: Trademark
Register Type: Principal
Published For Opposition Date: Not Available
Current Owner: Glaxo Group Limited
GSK Medicines Research Centre
Gunnels Wood Road
Stevenage SG12NY
UNITED KINGDOM
Mark Description: Not Available
Mark Drawing Type: Not Available
Design Search: Not Available
Disclaimer: Not Available
Correspondent: Christopher M. Hanes GSK
410 Blackwell Street
Durham, NC 27701
United States
   

 

Class Information

International Class(es):005
US Class(es):005, 006, 018, 044, 046, 051, 052
Primary Class:Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Class(es) Status:Active
First Use Anywhere: Not Available
First Use In Commerce:Not Available
Retrieve Trademark Documents